F01 in the Treatment of Relapsed/Refractory Non-hodgkin's Lymphoma
Clinical trial NCT06206902 · UNKNOWN
Trial details
- NCT number
- NCT06206902
- Sponsor
- Shanghai Simnova Biotechnology Co.,Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2025-01-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.